Lois Levine, MA

Medication therapy management can change the trajectory of patient health outcomes. Here is how pharmacists can ensure adherence and compensation.

The composition of the latest flu vaccine has changed. Here’s what pharmacists need to know.

From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.

In a world rich with diversity, pharmacists need to understand how varied backgrounds and special needs can impact a patient’s decisions in managing their health and medication protocols.

Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?

Listening carefully to determine what’s beneath the surface of a patient’s concerns can make a world of difference in providing quality care.

With an unprecedented number of Americans in need of mental health care, what role should pharmacists play when it comes to screenings?

The latest guidelines advise managing obesity first, then treating a patient’s other conditions to produce optimal outcomes.

As a result of an increase in adolescent inpatient visits with a sexually transmitted infection (STI) diagnosis in 2020, further work is needed to improve STI care, particularly for this demographic.

Of the 2596 patients included in the study, the hospitalization rates were 31.5% for Omicron, 27.7% for influenza, and 81.7% for RSV.

In January 2024, Sanofi and AstraZenenca will release 230,000 additional doses of nirsevimab-alip, heeding guidance from the CDC to leverage all tools to increase immunizations against RSV.

The mRNA-1010 vaccine generated a powerful response against 4 influenza virus strains compared to traditional flu shots.

The once-daily oral medication is the first and only treatment approved by the agency for adolescents with the disease.

A recent review evaluated possible approaches for new vaccines targeting respiratory viruses.

Out of an abundance of caution, the infant formula giant has recalled one of their powdered infant formula products because of a potentially dangerous bacteria.

A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19

The FDA has updated its compounding guidelines for licensed pharmacies, hospitals, and health systems.

Examining what immunotherapy can do for skin cancer treatment.

Valerie D. Callender, MD, FAAD, offers a look at the newest treatments available for acne and rosacea.

The benefits of COVID-19 vaccines for children, safety considerations, and the need to urge caregivers to get their children vaccinated.

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children of all ages and describes what is on the horizon for RSV.

Nonstimulant drugs and even nonmedication options are available for use.

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children.

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children and what is on the horizon for a potential RSV vaccine.

What pediatric health care providers should know about the 2022 Advisory Committee on Immunization Practices schedule updates.

At the 43rd National Conference on Pediatric Health Care for nurse practitioners in Dallas, Texas, a look at the newest medications for children with attention-deficit/hyperactivity disorder.

Researchers evaluated whether early gestational diabetes screening is associated with improved perinatal outcomes.

Sleep disorders can mimic symptoms of ADHD and providers should have a high index of suspicion when screening a patient for these conditions.

During a session at the 2021 American Academy of Pediatrics National Conference & Exhibition research revealed that introduction to common allergy foods early on can be key in decreasing the frequency of development in children.

At the virtual Scientific Sessions for the American Diabetes Association, Jennifer Sherr, MD, discussed the findings of a study of the Omnipod 5 automated insulin delivery system in very young children with type 1 diabetes.